W. Peter Sonsini
Affiliations
- Large Shareholder at Oyster Point Pharma Inc. (OYST), 2023-01-04
- Large Shareholder at Arcellx Inc. (ACLX), 2022-12-22
- Large Shareholder at Akouos Inc. (AKUS), 2022-12-02
- Large Shareholder at Ionq Inc. (IONQ), 2022-11-18
- Large Shareholder at Aveo Pharmaceuticals Inc. (AVEO), 2022-10-21
- Large Shareholder at Bright Health Group Inc. (BHG), 2022-10-20
- Large Shareholder at Zerofox Holdings Inc. (ZFOX), 2022-08-05
- Large Shareholder at Senti Biosciences Inc.\ (SNTI), 2022-06-15
- Large Shareholder at Genocea Biosciences Inc. (GNCA), 2022-05-26
- Director at Robinhood Markets Inc. (HOOD), 2022-05-04
- Large Shareholder at Trevi Therapeutics Inc. (TRVI), 2022-04-13
- Large Shareholder at Imara Inc. (IMRA), 2022-04-07
- Large Shareholder at Casper Sleep Inc. (CSPR), 2022-01-26
- Large Shareholder at Metacrine Inc. (MTCR), 2021-12-27
- Large Shareholder at Berkshire Grey Inc. (BGRY), 2021-07-30
- Large Shareholder at Monte Rosa Therapeutics Inc. (GLUE), 2021-06-30
- Large Shareholder at Desktop Metal Inc. (DM), 2021-06-10
- Large Shareholder at Eargo Inc. (EAR), 2021-05-26
- Large Shareholder at Reneo Pharmaceuticals Inc. (RPHM), 2021-04-15
- Large Shareholder at Marker Therapeutics Inc. (MRKR), 2021-03-18
- Other at Regulus Therapeutics Inc. (RGLS), 2021-03-17
- Large Shareholder at Savara Inc (SVRA), 2021-03-16
- Large Shareholder at Verona Pharma Plc (VRNA), 2021-01-05
- Large Shareholder at Mersana Therapeutics Inc. (MRSN), 2020-09-16
- Large Shareholder at Inozyme Pharma Inc. (INZY), 2020-07-28
- Large Shareholder at Annexon Inc. (ANNX), 2020-07-23
- Large Shareholder at Nkarta Inc. (NKTK), 2020-07-16
- Large Shareholder at Surface Oncology Inc. (SURF), 2020-05-22
- Large Shareholder at Champions Oncology Inc. (CSBR), 2020-03-10
- Large Shareholder at Black Diamond Therapeutics Inc. (BDTX), 2020-01-30
- Large Shareholder at Adaptimmune Therapeutics Plc (ADAP), 2020-01-28
- Large Shareholder at Ardelyx Inc. (ARDX), 2019-12-09
- Large Shareholder at Galera Therapeutics Inc. (GRTX), 2019-11-12
- Large Shareholder at Mirum Pharmaceuticals Inc. (MIRM), 2019-07-24
- Large Shareholder at Nightstar Therapeutics Plc (NITE), 2019-06-07
- Large Shareholder at Millendo Therapeutics Inc. (MLND), 2018-12-12
- Large Shareholder at Mulesoft Inc (MULE), 2018-05-09
- Large Shareholder at Tracon Pharmaceuticals Inc. (TCON), 2018-03-27
- Large Shareholder at Cascadian Therapeutics Inc. (CASC), 2018-03-13
- Large Shareholder at Arca Biopharma Inc. (ABIO), 2018-02-27
- Large Shareholder at Appian Corp (APPN), 2018-02-15
- Large Shareholder at Synlogic Inc. (SYBX), 2018-01-26
- Large Shareholder at Strongbridge Biopharma Plc (SBBP), 2018-01-09
- Large Shareholder at Arsanis Inc. (ASNS), 2017-11-20
- Director at Tintri Inc. (TNTR), 2017-06-29
- Large Shareholder at Achaogen Inc (AKAO), 2016-12-19
- Large Shareholder at Interleukin Genetics Inc (ILIU), 2016-08-02
- Large Shareholder at Cerecor Inc. (CERC), 2015-10-20
- Large Shareholder at Loxo Oncology Inc. (LOXO), 2014-08-06
Insider Trading: Purchases See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
TRVI | $1.90 | 948,948 | Large Shareholder | 948,948 | 2022-04-11 | Filing | |
TRVI | $1.90 | 2,631,578 | Large Shareholder | 10,421,428 | 2022-04-11 | Filing | |
TRVI | $0.00 | 1,851,852 | Large Shareholder | 7,789,850 | 2021-10-18 | Filing | |
GLUE | $19.00 | 1,050,000 | Large Shareholder | 7,692,298 | 2021-06-28 | Filing | |
MRKR | $1.75 | 5,714,285 | Large Shareholder | 10,714,285 | 2021-03-16 | Filing |
Insider Trading: Sales See All
Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|---|
GNCA | $0.08 | 4,445,093 | Large Shareholder | 0 | 2022-05-25 | Filing | |
GNCA | $0.07 | 5,931,843 | Large Shareholder | 4,445,093 | 2022-05-24 | Filing | |
MTCR | $0.91 | 170,932 | Large Shareholder | 2,563,257 | 2021-12-22 | Filing | |
MTCR | $1.00 | 288,768 | Large Shareholder | 2,734,189 | 2021-12-22 | Filing | |
MTCR | $1.32 | 37,570 | Large Shareholder | 3,022,957 | 2021-12-10 | Filing |